What does Bio Preventive Medicine Corp. do?

Bio Preventive Medicine Corp. (6810.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6810.TWO's market cap?

Bio Preventive Medicine Corp. (6810.TWO) has a market capitalization of approximately $1.09 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 6810.TWO pay a dividend?

No — Bio Preventive Medicine Corp. (6810.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 6810.TWO profitable?

Bio Preventive Medicine Corp. (6810.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6810.TWO

Bio Preventive Medicine Corp.

TWO·Biotechnology · Healthcare

NT$21.95NT$0.10+0.46%

Market capNT$1.09B·Aug 26 5:50 AM UTC

Price Chart

NT$21.95+NT$0.10 (+0.46%)today

+5.99%CAGR +1.17%

Select date range

FromTo

Aug 30, 2021Aug 30, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

6810.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$3.06M

Net Income−NT$98.17M

Net Margin−3,209.3%

Operating Cash Flow−NT$93.74M

Capital ExpendituresNT$1.78M

Free Cash Flow−NT$95.52M

Return on Equity−37.8%

Return on Invested Capital−13.3%

Net CashNT$99.92M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6810.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6810.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6810.TWO and 80,000+ other tickers.

About Bio Preventive Medicine Corp.

Bio Preventive Medicine Corp., a biotechnology firm currently in the clinical development phase, specializes in the proactive identification and mitigation of various illnesses. The company develops comprehensive strategies for the prevention, screening, and ongoing oversight of chronic conditions and cancer treatment. A key offering is the DNlite test, a suite of proprietary and medically validated non-intrusive urine analyses designed to aid in the management of diabetic kidney disease, encompassing specific products like DNlite-IVD103 and DNlite-DN_Score. Established in 2014, its main operations are located in Zhubei, Taiwan.

CEO: Tzu Ling Tseng
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 26
Website: www.bpmbiotech.com

Peers

Peers Tab

6814.TWO

Lukas Biomedical Inc.

Cap

NT$833.3M

7725.TWO

LabTurbo Biotech Corporation

Cap

NT$1.1B

6876.TWO

LAUNXP Biomedical Co., Ltd

Cap

NT$834.1M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6810.TWO

What does Bio Preventive Medicine Corp. do?: Bio Preventive Medicine Corp. (6810.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6810.TWO's market cap?: Bio Preventive Medicine Corp. (6810.TWO) has a market capitalization of approximately $1.09 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 6810.TWO pay a dividend?: No — Bio Preventive Medicine Corp. (6810.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 6810.TWO profitable?: Bio Preventive Medicine Corp. (6810.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.